Please note the Protocols are in PDF format and require Adobe Reader 5.0 or higher. If your computer has a lesser version of Adobe Reader installed the following links will probably open a new window with a blank screen. Please visit our File Formats page if you require further information.
The Transfusion Guidelines presented on this site are for use within King Edward Memorial Hospital for Women and Princess Margaret Hospital for Children. The guidelines are based on the National and International Blood Transfusion Guidelines and are intended to promote better and safer Transfusion Practice.
1.1 The Prescription of Blood Components
1.4 Clinical Indications For Blood Products
2.1 Completion of PathWest Transfusion Request Form
2.2 Collection of Pre Transfusion Samples
2.3 Correct Patient Identification During Sample Collection
2.7 The Role of the Group and Hold Request
2.8 Pre Transfusion Testing for Neonates
2.9 Maximum Surgical Blood Order Schedule (MSBOS)
3.1 Urgent Blood Transfusion Requests
3.2 Emergency Uncrossmatched Blood
3.3 PMH Emergency O Rh D Negative Blood for Out of Hours Use
3.4 PMH Massive Transfusion Guideline
3.5 KEMH Massive Transfusion Guideline
4.2 Collection of Blood Components from the Blood Bank
4.3 Issue Via The Vacuum Transport System
4.4 Storage of Blood Outside the Blood Bank
5.1 General Considerations for Blood Issue at PMH
5.3 Emergency O Rh D Negative Red Cells
6.1 General Considerations for Issue of Blood Components
7.1 General Considerations for Receipt of Blood Products
8.1 Pre Transfusion Checking Procedure
9.1 Standard Administration Checks and Filters
9.6 Calculating a Blood Transfusion Rate
10.1 Care and Monitoring of Transfused Patients
12.1 General Considerations in Adverse Events
12.2 Acute Transfusion Reactions
12.3 Delayed Haemolytic Transfusion Reactions
12.4 Other Delayed Complications
13.2 Paediatric Red Blood Cells
13.3 Platelets Single Donor Apheresis
13.6 Special Requirements for Blood Products
14.1 Overview of Plasma Derived Blood Components
14.7 Prothrombinex Factors II IX and X
14.11 Hepatitis B immunoglobulin
14.13 Intravenous Tetanus Immunoglobulin
15.1 Fetal Maternal Haemorrhage and Post Partum Complications
15.3 Anti D Immunoglobulin Products and Applications
16.1 General Considerations and Risks of Autologous Blood
16.2 Procedure for Autologous Blood Request
17.1 General Considerations of Intra Operative Cell Salvage
18.1 General Information for Clinicians
18.3 Informed Consent in Directed Donation
18.4 ARCBS Donor Selection Criteria
18.5 Directed Donation Procedure
19.1 Background - Recombinant Factor VIIa
19.2 Guidelines for use of Recombinant Factor VIIa
20.1 Procedure for Receiving Blood